0001437749-25-000736.txt : 20250108 0001437749-25-000736.hdr.sgml : 20250108 20250108163343 ACCESSION NUMBER: 0001437749-25-000736 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250108 DATE AS OF CHANGE: 20250108 EFFECTIVENESS DATE: 20250108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Luminary Therapeutics, Inc. CENTRAL INDEX KEY: 0001793860 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-470421 FILM NUMBER: 25518946 BUSINESS ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 BUSINESS PHONE: 612-309-7653 MAIL ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 D/A 1 primary_doc.xml X0708 D/A LIVE 0001793860 Luminary Therapeutics, Inc. 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 612-309-7653 DELAWARE None None Corporation true Jeff Liter 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Executive Officer Director Promoter John Wells 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director James Haymaker 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Promoter Tracey Lodie 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Mark Chance 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Jeff Ross 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Biotechnology Decline to Disclose 06b true 0001437749-23-021823 2022-09-28 true true true SAFE (Simple Agreement Future Equity) false 0 5500000 5222095 277905 false 49 0 0 0 false Luminary Therapeutics, Inc. /s/ Jeff Liter Jeff Liter President and Chief Executive Officer 2025-01-08